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The graft-vs.-host reaction (GVHR) 1 is initiated by immune responses of donor T 
lymphocytes to allogeneic histocompatibility antigens of the recipient. These  initial 
reactions cause a  chain of complex and sometimes antagonistic events that can result 
in various pathological symptoms. One possible outcome of the GVHR  is acute GVH 
disease (GVHD).  It is caused by donor T  cells (1-3) and produces thymic involution 
(1) and severe hypoplasia of the lympho-hemopoietic tissue (1, 4), including depletion 
of plasma  cells  in  the  gut  (5).  The  resulting  clinical  symptoms  of acute  GVHD 
comprise aplastic anemia  (1), severe immunodeficiency, including hypogammaglob- 
ulinemia (1, 6), and, finally, sepsis. Often, acute GVHD  terminates as lethal GVHD 
(LGVHD).  A  different possible outcome of the GVHR  is chronic GVHD.  This  is a 
pleiotropic syndrome, which can manifest itself by lymphoid hyperplasia, hypergam- 
maglobulinemia,  autoantibody formation,  and/or  symptoms  of collagen disease  (4, 
7-9).  The  mechanisms  that  determine whether  donor  T  cells will  induce  acute  or 
chronic  GVHD  and  the  pathological  symptoms  associated  with  them  are  poorly 
understood.  Alloreactive T  cells are known to consist of functionally distinct subsets 
that can be separated, for instance, on the basis of differences in their Lyt phenotypes 
(10,  11). Conceivably, the different and sometimes diametrically opposed pathological 
symptoms of GVHR  are due to differences in subpopulations of the alloreactive donor 
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T  cells administered to the recipients. Thus  far, however,  there is only little experi- 
mental data supporting this concept (12-15). Several authors have implicated T  killer 
(TK)  cells of the donor as the main effeetor cells that kill the recipients in LGVHD 
(16-19). This straightforward explanation has recently been questioned, however, and 
it has been suggested that  alloreactive T  suppressor (TS)  cells are the main effector 
cells causing LGVHD  (13,  14). 
In the present study, a  novel experimental approach was chosen for preparing two 
inocula of syngeneic T  cells that were enriched for allosuppressor and allohelper cells, 
respectively. T  cells from C57BI/10ScSn  (B 10) donors were first activated for different 
times, either 5 or 6 d, in the spleens of irradiated (B10 ×  DBA/2)F1  (1 °  F1) mice, and 
then assayed for their anti-F1 activities by transferring them to secondary F1  (2 °  F1) 
mice or testing them in vitro. Although donor T  cells activated for 5 d  were found to 
be  enriched  for  alloreactive TS  cells,  T  cells  activated  for  6  d  were  enriched  for 
alloreactive T  helper  (TH)  cells. Although both  day-5- and  day-6-activated T  cells 
were equally capable of lysing F1 target cells in vitro, nevertheless, upon  transfer to 
nonirradiated  2 °  F1  mice,  only  day-5-activated T  cells  induced  LGVHD.  Day-6- 
activated  T  cells, on  the  other  hand,  induced  symptoms  of chronic  GVHD  upon 
transfer to nonirradiated 2 °  F1 mice. 
Materials  and  Methods 
Mice.  B10 mice and (B10 ×  DBA/2)F1 hybrids were purchased from the TNO Laboratory 
(Zeist, The  Netherlands).  The  B10  donors  were  males or females, 6-12-wk old.  The  1  °  Fl 
recipients (Fig. 1) were males or females 10-12 wk old, and the 2 ° FI recipient mice were males 
or females 8-12 wk old. In a given experiment, all mice were of the same sex. 
Irradiation of Mice.  Mice were subjected to 750 rad total body irradiation by applying 662 
KeV gamma rays, emitted from a  laTCs source (Gammator, model 381,  Isomedic) at a dose of 
375 rad/min. Within the next 3 h, the mice were injected with the cells indicated. 
Preparation and Testing of Day-5- and Day-6-Activated Anti-F1 T Cells.  Single-cell suspensions of 
spleen cells were prepared as described (13). Spleen cells enriched for T cells were obtained by 
passage over nylon wool (20).  The basic experimental design for preparing day-5- and day-6- 
activated parental T  cells and for testing their capacities to induce LGVHD is depicted in Fig. 
1. In experiments in which the effects of the activated T  cells on erythropoiesis or on antibody 
formation  to  levan  were  studied,  smaller  numbers  of activated  cells  were  transferred  to 
irradiated 2 ° recipients of F1 or B10 origin (other than shown in Fig. 1). 
Complement (C)-dependent Cytotoxiclty Test.  The trypan-blue exclusion method was used. A  1 
in 1,000 dilution of the monoclonal anti-Thy-1.2 antibody was used for the determination of T 
cells. Cells of F1 origin were identified with a  1 in  10 dilution of a  B10 anti-DBA/2 and  a 
DBA/2 anti-B10 alloantiserum, respectively, which were prepared by repeated injections of 
lymphoid cells. The Lyt phenotypes of activated B 10 cells were determined with anti-Lyt-1.2 
and anti-Lyt-2.2 sera, respectively, at a dilution of 1 in  10. As a source of C we used a  1 in  12 
dilution of serum obtained from selected rabbits. 
Cell-mediated Lymphocytotoxicity (CML)  Test.  Two  different  experimental  protocols  were 
applied to assess the 4-h CML activity of day-5- and day-6-activated B10 T  cells. In the first 
protocol, the activated T  cells obtained from the spleens of the 1  ° F1 mice were cultured for 18 
h without the addition of stimulator cells and then tested by CML. In the second protocol, 1.2 
×  10  7 day-5- or day-6-activated cells were first restimulated by mixing them with 1.2 ×  107 F~ 
spleen cells irradiated with 3,300 rad. The cell mixtures were cultured for 5 d at a 5-ml volume 
in tissue-culture flasks (3013;  Falcon Labware, Div. of Becton, Dickenson & Co., Oxnard, CA). 
The restimulated cells were then tested by CML. The culture conditions, determination of 4-h 
CML  activity, and  inhibition of CML  activity by unlabeled target  cells were  the same  as 
described elsewhere (13). ROLINK  ET  AL. 
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FiG.  1.  Experimental design for the preparation and testing of day-5- and day-6-activated B10 T 
ceils. On day zero, 50 ×  106 splenic T  cells from BI0 donors were injected into H-2-incompatible 
irradiated  (BI0 ×  DBA/2)F1 hybrids, termed primary Fj  (1 °  F1)  mice. Cells were recovered from 
the spleens of 1  °  F1 mice, either on day 5 or day 6; they were termed day-5-activated and day-6- 
activated B 10 T  cells, respectively. For assessment of the functional capacities of day-5- and day-6- 
activated T  cells, cells of either population were transferred to secondary (2 °) recipients. When the 
capacities of the two populations of activated parental T  cells for induction of LGVHD were to be 
studied,  3  ×  10  v live cells of either  population  were  transferred  into  nonirradiated  FI  (2 °  Fj) 
recipients (see figure). In experiments in which the effects of day-5 and day-6 cells on erythropoiesis 
or antibody production were studied, smaller numbers of day-5 and day-6 cells, along with other 
cells, were transferred into irradiated 2 ° recipients, as described in the text. Alternatively, different 
numbers of activated T  cells were studied in vitro. 
Quantitation of Mouse IgG in the Supernatants of Cultured Spleen Cells and in the Serum.  This assay 
was performed as described (13). 
Determination of Hemopoiesis by Incorporation of 5eFe.  This  assay  was  performed as described 
(21). 
Anti-Levan Plaque-formin~  Cell (PFC) Response.  Irradiated 2 ° recipient mice were repopulated 
intravenously with 3  X  10  T  cell-depleted spleen cells and various numbers of day-5- or day-6- 
activated B10 cells. 2  d  later, the mice were injected intravenously with  10 p,g levan. 5 d  after 
injection of the T  cell-independent antigen levan, the spleens of the mice were removed, and 1504  ALLOSUPPRESSOR  T  CELLS  IN  LETttAI, GRAFT-VS.-ItOST DISEASE 
the direct PFC responses of individual mice were determined by applying a Jerne-plaque assay 
with levan-coupled sheep erythrocytes (SRBC)  (22). 
Ig Allotype.  Antisera specific for the Ig-I b allotype of B10 and the Ig-1  c allotype of DBA/2, 
respectively, were  prepared  as described  (23).  The  anti-Ig-1  c serum was  used at  a  constant 
dilution of  1 in  3  and  the  anti-Ig-1  h serum  at  a  constant  dilution of  1 in  9.  The  relative 
concentrations of Ig allotypes in the sera of 2 °  F1 recipients of day-6 cells were determined by 
double-immunodiffusion in agar gel. The sera of 2 °  F1 mice were tested at doubling dilutions 
starting at  1 in 8.  The titer of the highest serum dilution that  gave a  precipitation line was 
recorded. 
Pathological Examination.  At  autopsy,  organs  were  removed  and  fixed  in  8%  phosphate- 
buffered  formalin  (pH  7.4),  embedded  in paraffin, and cut  at  5  p,m.  Sections stained with 
hematoxylin-eosin or Giemsa stain were prepared. 
Immunofluorescence and Immunoperoxidase Examination.  Indirect  immunofluorescence staining 
was performed on frozen sections of lymph nodes and spleens of the 2 °  F1 recipients. For the 
determination  of T  cells,  a  suitably  absorbed  rabbit-anti-mouse brain  serum  was  used  in 
combination with a  horse-anti-rabbit IgG labeled with tetramethylrhodamine isothiocyanate 
(17-2T2; Central Laboratory of the Netherlands Red Cross Blood Transfusion Service [CLB], 
Amsterdam). Direct immunofluorescence staining was used for the determination of B cells and 
plasma cells, applying a  rabbit-anti-mouse Ig serum labeled with  fluorescein isothiocyanate 
(KM  16-11; CLB, Amsterdam). 
Immunoperoxidase studies  for  the  detection  of  intracytoplasmic Ig  in  plasma  cells  and 
plasma-cell precursors in the lamina propria of the upper part of the small bowel (duodenum 
and jejunum) were performed in paraffin sections, pretreated with protease  (type VII; Sigma 
Chemical Co., St.  Louis, MO)  (24).  Rabbit antisera against mouse IgG, IgA, and IgM (Miles 
Laboratories, Elkhart, IN) were diluted 1 in 20 (IgG) and 1 in 10 (IgA and IgM), respectively. 
Swine-anti-rabbit serum (Dakopatts, Copenhagen, Denmark) was used in a dilution of 1 in 40, 
and the peroxidase-antiperoxidase complex produced in swine (Dakopatts) was diluted 1 in 50. 
All dilutions were made in normal swine serum (Dakopatts). 
Primary PFC Responses against SRBC In Vitro.  3 X  10  ~ normal spleen or T  cell-depleted spleen 
cells were  cultured  in volumes of 300 p.l  together with  various numbers of day-5- or day-6- 
activated B I0 cells or "activated" T  cells of F1 origin. The latter were nylon wool-passaged Ft 
spleen cells injected into 1  o Fx mice and recovered from their spleens on day 5 or day 6. Cultures 
were performed in Falcon multi-well tissue-culture plates (3008; Falcon Labware). The culture 
medium consisted of sodium-bicarbonate-buffered RPMI 1640 supplemented with e-glutamine 
(2 raM), 2-mercaptoethanol (2 X  10  -s M), streptomycin (50 U/ml), penicillin (50 U/ml), and 
10% fetal calf serum (FCS). The cultures were immunized with 2.5 x  l0  s SRBC. On day 4, the 
numbers of direct PFC were determined in a Jerne-plaque assay. Triplicate cultures were set 
up for each determination. 
Preparation of T Cell-depleted  Spleen Cells (B Cells).  B cells were prepared by incubating spleen 
cells with monoclonal anti-Thy-l.2 (clone F7D5; Olac  1976 Ltd., Bicester, United Kingdom) 
and C, as previously described (13). Thereafter, the cells were washed three times and viable T 
cells determined by indirect immunofluorescence with an appropriately absorbed rabbit anti- 
mouse-brain serum in combination with fluorescein isothiocyanate (FITC)-labeled swine-anti- 
rabbit IgG (F2190; Dakopatts). The proportion of T  cells never exceeded  1%. 
Statistical Significance.  Student's t test was applied. 
Results 
Serological Characterization of Day-5- and Day-6-activated  Cells.  The absolute numbers 
of live cells recovered from the spleens of 1  °  F1 mice on day 5 did not differ from those 
recovered  on day 6.  On  both days, the recovery per spleen varied from  1.4 ×  107 to 
2.1  ×  107 cells in different experiments. About 90% of the live cells recovered on both 
days  5  and  6  were  T  cells  of  B10  origin  (Table  I).  Viable  cells  of  FI  origin,  as 
determined by a  cytotoxic antiserum against DBA/2, were undetectable among both 
day-5  and  day-6 cells.  Therefore,  the  two  cell  populations were  termed  day-5- and ROLINK  ET  AL. 
TABLE  I 
Day-5- and Day-6-Activated Cells Are B10 T  Cells with the Same Lyt Phenotypes 
1505 
Spleen cells of  Percentages of cells killed with antiserum and C* 
1  ° Fi recipients  Anti-  Anti- 
obtained on  Thy-l.2  C57B1/10  Anti-DBA/2  NMS  Anti-Lyt-l.2  Anti-Lyt-2.2 
mean 4- 1 SE 
Day 5  92 4- 3  85 4- 4  12 4- 3  10 :t: 2  65 4- 6  66 4- 4 
Day6  924-4  87+2  124-4  11  4-3  624-4  674-3 
* Results of three individual experiments, each of which was performed with pooled spleen cells from 5 to 
15 primary F~ mice. 
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Fie.  2.  Different capacities of day-5- and day-6-activated BI0 T  cells for induction of LGVHD. 
Nonirradiated 2  ° F] mice received either 3 ×  10  7 day-5-activated or 3 ×  107 day-6-activated T cells. 
The results represent the cumulative data from four subsequent experiments 
TABLE  II 
Effects of Day-5- and Day-6-activated B I O T  Cells upon the Body  Weight, 
Hematocrit  Value, and Serum-lgG Concentration of 2 °  Recipients 
2  ° recipients*  Time of 
activation 
Mean se- 
(in  1  ° F 0  Mean body  Mean  rum-IgG 
of B 10 T  Strain  weight 4- 1  hematocrit 
cells  SEM  4-  1 SEM  concentra- 
tion +  SE 
d  g  % of controls 
5  (B10 ×  DBA/2)F~  15.0 4- 2.6  14.8 +  3.9  38 +  10:~ 
6  (B10 ×  DBA/2)F]  21.0 4- 0.8  48.8 4- 2.1  276 +  60:1: 
5  BI0  20.34-0.9  48.34-0.3  1054-  11§ 
6  B10  21.0 + 0.4  50.7 4- 0.9  99 4- 9§ 
* Each group of recipients consisted of three to five mice. All mice were tested 
20 d after the injection of activated T cells. 
:~ P <  0.05 when compared with the 100% values of noninjected Fl mice. 
§ P >  0.2 when compared with the 100% values of noninjected B 10 mice. 
day-6-activated B10  T  cells, respectively, although  minor contaminations  by non-T 
cells and/or  FI  cells might have remained  undetected  (21).  The  percentages of Lyt- 
1+2 -  cells  and  Lyt-l-2 +  cells  among  day-6-activated T  cells  were  not  significantly 
different from those found among  day-5-activated T  cells (Table I). 
Different Capacities for Induction of LGVHD.  Groups of nonirradiated 2 ° F] mice were 
injected with either 3  ×  107  day-5-activated or 3  ×  107  day-6-activated B10 T  cells. 
Of  the  2 °  F1  recipients of day-5-activated T  cells,  92%  died  from GVHD  (Fig.  2). 1506  ALLOSUPPRESSOR  T  CELLS  IN LETHAL GRAFT-VS.-HOST  DISEASE 
TABLE III 
Weights of, and Cell Numbers in, the Spleens of 2 ° F; Mice at 14 dafter the 
Injection of Day-5 or Day-6 Cells 
Mean number of nu- 
2 °  F1 mice* injected  Mean spleen weight 
with  +  1 SEM  cleated cells per spleen 
(X  10  7  )  +  1 SEM 
mg 
Nothing  127 + 4  6.6 + 0.7 
Day-5 cells  137 + 24~:  2.0 + 0.25§ 
Day-6 cells  273 + 4911  7.3 zt: i.I¶ 
* Each group consisted of six Fl mice. 
~: Significantly different (P <  0.05) from the group injected with day-6-acti- 
vated cells, but  not significantly different (P >  0.1) from the noninjected 
group. 
§ Significantly different (P < 0.005) from the other two groups. 
II Significantly different (P < 0.005) from the noninjected group. 
¶ Not significantly different (P > 0.1) from the noninjected group. 
Such  2 °  F1  recipients  showed  characteristic  symptoms  of acute  GVHD,  such  as 
reduced body weight and hematocrit, a decreased level of serum IgG, and a decreased 
number of cells in their spleens  (Tables II and III). In marked  contrast, none of the 
2 °  Fa recipients of day-6-activated T  cells died from or showed clinical symptoms of 
acute GVHD  (Fig. 2, Table II). However, at 2 wk after the transfer of day-6-activated 
T  cells, the 2 ° F1 recipients showed splenomegaly and a slight increase in the number 
of cells in their spleens (Table III). Typing of these cells in a C-dependent cytotoxicity 
test, applying an anti-Bl0 and an anti-DBA/2 serum, showed that at least 90% were 
of F1  origin  (data  not  shown).  Furthermore,  the  injection  of day-6  cells  caused  a 
considerable increase in the serum IgG level of 2 ° F1 recipients (Table II). By applying 
an  anti-Ig-1 b  and  an  Ig-1  c  serum  for  immunoprecipitation  in  agar  gel,  it  was 
demonstrated that the levels of both Ig-1 allotypes were increased in the sera of 2 °  F1 
recipients of day-6 cells (data not shown). This indicated that at least a  major portion 
of the increased serum  IgG level in these mice was produced  by B cells of the 2 °  F1 
mice, which were Ig-1  b/c, and not by B cells of B10 origin  (Ig-lb/b). When syngeneic 
(B 10) mice instead of F1 mice were used as 2 ° recipients, neither day-5 nor day-6 cells 
induced clinical abnormalities  (Table II). 
Morphological Findings in the Lympho-Hemopoietic  Tissues of 2 °  Recipients.  Inoculation 
of day-5-activated T  cells into 2 °  F1 recipients caused a  progressive hypoplasia of the 
peripheral  lymphoid tissues and the thymus. Immunofluorescence studies of T  and B 
cells in the spleens and lymph nodes of such 2 °  F~ recipients showed that virtually all 
of the  few  lymphoid  cells  present  were  T  cells.  In  contrast,  inoculation  of day-6- 
activated T  cells into 2 ° Fa mice caused stimulation of the peripheral lymphoid tissues 
and  no involution  of the thymus. The lymphoid stimulation  induced by day-6 cells 
was already present  10 d  after the cell transfer and, in five out of six 2 °  FI recipients 
studied,  persisted  for at  least  3  mo.  Immunofluorescence studies  of the  stimulated 
spleens and lymph nodes of 2 ° F1 recipients of day-6 cells showed that the T  cell areas 
and, especially, the B cell areas, were stimulated. 
In  control  experiments,  syngeneic  (B10)  mice,  instead  of F1  mice,  served  as  2 ° 
recipients  of day-5  and  day-6  cells,  respectively.  Neither  lymphoid  hypoplasia  nor 
thymus involution were observed in these recipients;  however, both day-6 and day-5 ROLINK ET AL.  1507 
cells induced a moderate and transient lymphoid stimulation, which had disappeared 
at  day  40  after  the  cell  transfer.  There  are  at  least  three  possible,  mutually  not 
exclusive explanations for this transient lymphoid stimulation:  (a) small numbers of 
F1 cells might have been co-transferred from the  1  °  F~ animals to the 2 °  BI0 mice 
and might thus have provided an alloantigenic stimulus;  (b) the alloactivated B 10 T 
cells themselves might  have picked Fa antigens  (25)  that  then elicited an  immune 
response  in  the  2 °  B10  mice;  (c)  the  2 °  B10  recipients  might  have  responded  to 
idiotypic receptors on the alloactivated syngeneic T  cells (26). 
After the injection of day-5 cells, hemopoiesis in the bone marrow of 2 ° F1 recipients 
was moderately suppressed after 10 d  (Fig. 3 A) and was no longer detectable after 20 
d. However, a conspicuous depletion in the numbers of the reticular fibroblasts in the 
marrow was undetectable in the 2 ° F~ recipients of day-5 cells (nor were such changes 
detectable in any other group). In all 2 ° Fa mice injected with day-6 cells, by contrast, 
the bone marrow showed fully developed hemopoiesis at days 10, 20, 30, and 90 (Fig. 
3 B). No hypoplastic changes were detectable in the bone marrow of syngeneic (B10) 
recipients of either day-5 or day-6 cells. 
Morphological Findings in the Gut and Other Organs of 2 ° Recipients.  Whereas in the 2 ° 
F1 recipients of day-5 cells there was a progressive disappearance of plasma cells and 
their precursors in the lamina propria of the small bowel, no such changes were found 
in  the  2 °  Fa  recipients  of day-6  cells.  In  both  groups,  however,  small  foci  of 
lymphocytes, obviously invading the epithelium, were found in the crypts. In addition, 
villous edema and focal superficial epithelial necrosis were present in these areas. In 
contrast, the injection of neither day-5 nor day-6 cells changed the number of plasma 
cells or caused epithelial lesions in the intestinal villi of syngeneic (B10) recipients. 
The above-mentioned histological findings were confirmed by the  results of im- 
munoperoxidase staining. After the injection of day-5 cells, the 2 ° F1 recipients showed 
a  progressive depletion of IgG-, IgM-, and IgA-containing plasma cells and plasma- 
cell precursors in the lamina propria of the gut  (Fig. 4A).  In contrast, at all times 
after the transfer of day-6 cells, the guts of 2 °  F1 animals contained numerous cells 
cytoplasmically positive for IgA, IgM, or IgG (Fig. 4 B).  Both day-5 and day-6 cells 
failed to change the number of isotypes of Ig-producing ceils in the gut of syngeneic 
(B 10) recipients. 20 d after the cell transfer, the 2 ° F1 recipients of day-5 cells but not 
those of day-6 cells showed histological signs of sepsis in that bacterial colonies without 
inflammatory reaction were found in the liver and other parenchymal organs. 
Lack  of Difference  in  Anti-F1  TK  Cell  Activity  between  Day-5-  and  Day-6-activated 
Cells.  Both day-5- and day-6-activated B10 T  cells lysed F1 target cells in vitro but 
failed to lyse syngeneic (B10) target cells (Fig. 5). When day-5 and day-6 cells were 
restimulated  for 5  d  with  irradiated Fa spleen cells in  vitro before being tested by 
CML, they had retained their cytotoxic anti-F1 activity, but again we did not lind 
that the anti-F1 TK cell activity of day-6 cells was inferior to that of day-5 cells (data 
not shown). Cold-target inhibition studies indicated that the anti-F~ TK cell activity 
of both  day-5  and  day-6-activated B10  (H-2  b/b)  T  cells was  specific for the  H-2  d 
antigens of (B 10 ×  DBA/2)F1 (H-2  b/d) mice. Specificity for non-H-2 antigens was not 
observed (data not shown). As far as the anti-H-2  ~ specificity of day-5-activated B 10 
TK  cells  is  concerned,  the  results  of cold-target  inhibition  studies  were  reported 
elsewhere (13). 
Differences in Allogeneic Helper and Suppressor Effects of Day-5- and Day-6-activated T Cells C
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Ftc.  5.  Lack of difference in cytotoxic anti-F~ activity between day-5- and day-6-activated T  cells. 
After activated BI0 T  cells had. been recovered from two groups of 1  °  FI  mice, they were ke~t in 
culture for  18 h. Thereafter, they were simultaneously tested by CML on Con-A-activated,  ~Cr- 
labeled (B10 x  DBA/2)Fl spleen cells (© and Q) or B10 spleen cells (O and m). 
~day 5-activated 
.~700 t~ daY 6 "activated 
100  ~ 
5  6 
days of activation of 
C57BI/10 Tcells 
Fro.  6.  Opposite effects of day-5 and day-6-activated T  cells upon the IgG production by spleen 
cells of 2 °  Ft  recipients. Nonirradiated 2 °  F1 animals received either 3 ×  107 day-5-activated or 3 
×  107 day-6-activated T  cells. After 14 d, the spleens of 2 ° Fl mice were excised, and 2.5 ×  l0  T cells 
of each mouse were cultured overnight. The IgG concentrations in the culture supernatants were 
determined  and  expressed as  the  percentage of IgG  concentration  found  in  cultures containing 
spleen cells of noninjected Fl mice.  (The  100% value corresponds to  1 l  250 ng IgG).  Each group 
consisted of five F~ mice. Columns represent the arithmetic mean; vertical bars represent  1 SEM. 
on the IgG Production by Spleen Cells of 2 o ['1 Mice.  Groups of nonirradiated 2 ° F1 mice 
were injected with 3 ×  107 day-5- or day-6-activated cells. After 14 d, the spleen cells 
of the 2 °  F1 recipients were assayed in vitro for the amount of IgG released into the 
culture  supernatant.  Spleen  cells  obtained  from  day-5-injected  2 °  F1  recipients 
produced only about one-fourteenth of the IgG produced by the same number of cells 
obtained from day-6-injected 2 ° F1 recipients (Fig. 6). However, the absolute number 
of cells in the spleen of 2 ° F1 mice injected with day-6 cells was more than three times 
higher  as  the  number of cells  found  in  2 °  FI  recipients of day-5 cells  (Table III). 
Therefore, when the IgG production was calculated on the basis of whole spleens, the 
difference in IgG production between those 2 °  Fa mice injected with day-5 cells and 
those injected with day-6 cells was even 40- to 50-fold. These data are consistent with 
the serum IgG levels of 2 ° F1 recipients of day-5 and day-6 cells, as shown in Table II. 
Different Effects of Day-5-  and Day-6-activated T  Cells on the Anti-Levan Response of F1 
Spleen Cells.  The effects of activated B10 T  cells on the PFC response to levan were ROLINK  ET  AL.  1511 
studied in irradiated  2 °  F1 mice. In the first  experiment  (Fig.  7), all seven groups of 
2 ° F1 mice were repopulated with a standard number of 3 ×  107 nonirradiated spleen 
cells from syngeneic F1 donors. Six groups received graded numbers of day-5- or day- 
6-activated T  cells in addition. All three groups of the repopulated 2 °  F1 mice that 
had received day-5 cells exhibited a dose-dependent suppression of the PFC response. 
In these three groups, the  PFC responses were significantly lower  (P <  0.002)  than 
those of 2 ° FI control mice. In contrast, day-6 cells, at doses of 1.25 ×  106 and 5 ×  106 
cells,  did not induce a significant suppression (P >  0.15). Although the PFC response 
120 
~.  ~day5-activated 
[]  day  6- activated 
100 
80 
40  : 
20  ..... 
0  1.25  2.50  5.00 
no. Of activated cells injected  (xlO 6) 
Fla.  7.  Different  effects  of  day-5-activated  and  day-6-activated  T  cells  upon  the  anti-levan 
response of Fj spleen cells. All seven groups of irradiated 2 ° Fj mice were repopulated with 3 ×  107 
FI spleen ceils. In addition, the mice of six groups received graded numbers of activated B10 T  cells, 
as  indicated.  On  day  2,  all  animals were immunized with  levan;  on  day  7,  the anti-~evan  PFC 
responses were  determined.  Each  group  consisted  of five  Fa  mice.  The  anti-levan  response  is 
expressed as the percentage of PFC found in 2 ° mice that were repopulated with 3 x  107 spleen cells 
alone.  (The  100% value  corresponds to  3,524  PFC.)  Columns  represent  the  arithmetic  means; 
vertical bars represent 1 SEM. 
120  c 
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Q. 
~  80 
~  60 
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no. of activated cells injected (xlO  6) 
FIe.  8.  Suppressive effect  of both day-5-  and  day-6-activated  BI0 T  cells  upon  the  anti-levan 
response of syngeneic BI0 B cells  in an F1 environment. All seven groups of irradiated  2 °  FI mice 
were repopulated with 3  ×  107  B10  spleen cells,  which had  been  treated  with anti-Thy-l.2 and 
complement. In addition,  the animals of six groups received  graded numbers of activated  BI0 T 
cells,  as indicated.  On day  2, the animals were immunized with levan;  on day  7, the anti-levan 
responses in their spleens were determined.  Each group consisted of five  Fl  mice.  The anti-levan 
response is expressed as described  for Fig.  7.  (The  100% value in this experiment corresponds to 
2,230  PFC.) 1512  ALLOSUPPRESSOR  T  CELLS  IN  LETHAL  GRAFT-VS.-HOST  DISEASE 
o 
2  3 
o 
=02 
Ck 
0  " 0.1  0.5  2.0  75  15.0 
no. of Tcells  added  per culture(xlO  5) 
FIG. 9.  Comparison of the amount of allohelper activity present among day-5-activated and day- 
6-activated T cells. The effects of these cells upon a primary anti-SRBC response by T cell-depleted 
Fl spleen cells were studied. A standard number of 3 ×  l0  s Fl spleen cells, which had been treated 
with anti-Thy-l.2 and complement, were cultured together with SRBC and graded  numbers of 
activated BI0 T cells (O and 0) ofFl T cells (A). Direct anti-SRBC PFC responses were determined 
on day 4. The arithmetic means of triplicate cultures are shown; vertical bars indicate 1 SEM. 
i 
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6O 
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FIG.  10.  Comparison of the amount of allosuppressor activity present among day-5-activated and 
day-6-activated T cells. The effects of these cells upon a primary anti-SRBC response by normal F] 
(C) and 0) or BI0 (["1 and I)  spleen cells were studied. A standard number of 3 ×  l0  s spleen cells 
were cultured together with SRBC and graded numbers of activated BI0 T cells, as indicated. The 
numbers of PFC were determined and expressed as described for Fig. 8. At each point, the value of 
I SEM was <8%. (The 100% value corresponded to 850 PFC per culture.) 
of 2 °  F1 recipients of 2.5 ×  106 day-6 cells was significantly lower (P <  0.01)  than  that 
of the control mice, it was still significantly higher (P <  0.01)  than  the response of the 
group  injected with day-5 cells. 
Next, we investigated whether  day-5 cells were also able to suppress the anti-levan 
response of syngeneic  (BI0)  cells in  an  F1  environment,  Irradiated  2 °  F1  mice  were 
therefore repopulated  with a  standard  number  of 3  ×  107 spleen cells of B10 origin. 
To prevent GVH  effects by the repopulating  B 10 spleen cells themselves, we used B 10 
spleen cells that  were  depleted  of T  cells  ("B" cells).  In  addition  to receiving  BI0  B 
cells, 6  groups of the 2 °  F1 mice received graded  numbers  of day-5- or day-6-activated 
B10  T  cells.  In  the  environment  of the  irradiated  2 °  F1  recipients,  day-5-activated ROLINK  ET  AL.  1513 
B10 T  cells were capable of suppressing the  PFC  response of B10 B  cells  (Fig.  8). 
Surprisingly, however, even day-6-activated T  cells at doses of 2.5 and 5 ×  106 cells 
caused a significant (P <  0.05) suppression of syngeneic B cells in 2 ° F1 recipients. 
The Different  Capacities  of Day-5- and Day-6-activated B I O T  Cells for Induction  of Positive 
and Negative Allogeneic Effects In  Vitro.  Helper effects of activated B 10 T  cells upon the 
primary  anti-SRBC  response of F1  B  cells  ("allohelp")  were assayed  by culturing 
graded numbers of day-5 or day-6 cells with 3 X  106 unprimed Fx B cells and SRBC. 
The help supplied by day-6 cells was considerably higher than that induced by day- 
5 cells. However, day-5 cells, too, were able to induce allohelp because many fewer 
day-5-activated B 10 T  cells than syngeneic T  cells were needed for providing help to 
the F1 B cells. Moreover, day-6 cells at doses of 2 ×  105 and higher were also able to 
suppress F1 B cells, when compared with syngeneic T  cells (Fig. 9). 
In another experiment (Fig. 10), the suppressor effect of activated B 10 T  cells upon 
the primary anti-SRBC response of F1 spleen cells ("allosuppression") was tested. To 
this end, 3  X  106 unprimed Fa spleen cells (instead of the Fa B cells as used in the 
previous experiment) were cultured with graded numbers of day-5 or day-6 cells and 
SRBC.  Addition  of very small  numbers  of day-5  cells  already  induced  a  distinct 
suppression of the PFC response by F1 spleen cells: the addition of only 103 day-5 cells 
suppressed almost 50% of the PFC response. This suppression of the response became 
more  profound  when  higher  numbers  of day-5  cells  were  added  to  the  cultures. 
Although day-6 cells, too, were able to suppress the response, this occurred only at cell 
numbers of 32 ×  103 and higher, and then the extent of suppression was significantly 
lower (P <  0.03) than that induced by day-5 cells.  No suppression was observed when 
day-5- or day-6-activated B10 T  cells were added to syngeneic B10 spleen cells (Fig. 
9).  This indicates that,  for suppression to occur, allorecognition by the activated T 
cells had to be possible. The finding that addition of 0.25 to 64 ×  103 "activated" F1 
TABLE  IV 
Erythropoietic Activities of Various Cell Populations Separately Injected into 
Irradiated 2 ° Ft Mice 
Origin  and  number  of cells  transferred 
(x lO  ~) 
Day-5  Day-6  B10  F1  BMC 
ceils  cells  BMC 
SgFe incorporation  in  the 
spleen  of  2 °  F1  recipients* 
mean  cpm  4" SD 
--:[:  --  --  --  309  ±  160 
0.6  --  --  --  329  ±  102 
1.2  --  --  --  410  ±  154 
2.4  --  --  --  490±  141 
--  0.6  --  --  352  ±  130 
--  1.2  --  --  267  ±  72 
--  2.4  --  --  463  ±  172 
--  --  2  --  617  ±  391 
--  --  20  --  14,231  ±  2,830 
--  --  --  2  11,298  ±  633 
*  Each  group  consisted  of  five  irradiated  Fl  mice. 
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Ft~.  1 l.  Opposite effects of day-5-activated and day-6-activated T cells on the hemopoietic activity 
ofFj BMC. On day 0, irradiated 2 ° Fl mice were repopulated with 2 X  106 BMC from normal Fj 
mice and graded numbers of activated B10 T  cells,  as indicated. On day  7, the amount of ~gFe 
uptake in the spleens of the repopulated mice was determined. Each group consisted of five F] mice. 
The data are expressed as mean percentages of the 5~Fe uptake found in those 2 °  mice that had 
been repopulated with BMC alone. Vertical bars indicate 1 SEM. 
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F[c.  12.  Suppressive  effects  of both  day-5-activated  and  day-6-activated  BI0  T  cells  on  the 
hemopoietic activity of B10  BMC  in an F1 environment. On day 0,  irradiated  2 °  F1  mice were 
repopulated with 2 ×  107 BMC from normal B10 mice and graded numbers of activated BI0 T 
cells, as indicated. On day 7, the amount of 59Fe uptake in the spleens of the repopulated mice was 
determined. Each group consisted of five Fl mice. Results are expressed as described for Fig.  l 1. 
T  cells  to  the  F1  spleen  cells  likewise  failed  to  suppress  the  PFC  response  (data  not 
shown)  is consistent with this conclusion. 
The  Different  Capacities  of Day-5-  and Day-6-activated  BIO  T  Cells for  Suppression  of 
E~ythropoietic ['1  Cells.  Before  the  effects  of day-5-  and  day-6-activated  parental  T 
cells upon  the hemopoietic  activity of BMC  could be studied, we had  to exclude the 
possibility that day-5 and day-6 cells themselves had a  different erythropoietic activity. 
Therefore, equal numbers  (0.6 ×  106 to 2.4 ×  106) of day-5 or day-6 cells were injected 
into  groups  of irradiated  2 °  F1  recipients,  who  did  not  receive  any  other  cells.  7  d 
later, the 59Fe incorporation  into the spleen of the 2 °  F1 mice was determined.  Neither 
the  2 °  F1  recipients  of day-5  cells  nor  those  of day-6  cells  contained  a  significantly 
higher  erythropoietic  activity  than  unrepopulated  2 °  F1  mice  (Table  IV).  Table  IV ROLINK ET AL.  1515 
also  shows  the  different  repopulating  capacities  of F1  BMC  and  BI0  BMC.  The 
number of B10 BMC that was required to give a  good SgFe uptake in the spleens of 
the irradiated 2 ° F1 recipients, was  10 times as great as the number of Fa BMC. The 
large number of B10 BMC was needed to overcome the F~ hybrid resistance of the 
irradiated Fx mice to hemopoietic ceils of B 10 origin (27). 
We then studied the effects of the two kinds of activated parental T  cells on the 
hemopoietic activity of the  BMC  taken  to  repopulate irradiated  2 °  F1  recipients. 
Graded numbers of activated T  cells (0.6 ×  106 to 2.4 ×  106) were injected into the 
following kinds of irradiated 2 °  recipients:  (a)  F1 mice repopulated with 2 ×  106 F1 
BMC  (Fig.  11);  (b) F1 mice repopulated with 20 ×  I0  n B10 BMC  (Fig.  12), and  (c) 
B10 mice repopulated with 2 ×  106 B10 BMC. As can be seen in Fig.  11, day-5- and 
day-6-activated T  ceils exerted opposite effects on the repopulation by F~  BMC of 
irradiated F1  (2 °  Fx)  mice. To test whether day-5-activated B10 T  cells would also 
suppress syngeneic B10 BMC in an Fx environment, protocol (b) was used. All doses 
of day-5 cells markedly depressed the 59Fe uptake by syngeneic BMC  (Fig.  12).  By 
contrast, day-5-activated B 10 T cells failed to suppress, but stimulated the ~9Fe uptake 
of B10 BMC in the completely syngeneic environment described under (c) (data not 
shown). In summary, the results of experiments (b) and (c) indicate that the nonspecific 
suppression by day-5 cells of syngeneic B 10 BMC depended on the triggering of day- 
5 cells by Fa alloantigens. 
A surprising finding was that day-6-activated B 10 T  cells, too, although they failed 
to suppress erythropoietic cells of F1 origin (Fig.  11), did suppress the erythropoietic 
activity  of syngeneic BMC  in  an  F1  environment  (Fig.  12). In  the  absence  of F1 
antigens,  however,  neither  day-5-  nor  day-6-activated  B10  T  cells  suppressed  the 
erythropoiesis of B10 BMC, but rather stimulated it (data not shown). 
Discussion 
We prepared two functionally different subpopulations of alloactivated parental T 
lymphocytes: day-5 cells,  which  were enriched for T  cells inducing  LGVHD,  and 
day-6 cells, which were unable to induce LGVHD (Fig. 2). In addition, upon transfer 
to the nonirradiated 2 ° Fx mice, day-5-activated T cells suppressed the IgG production 
by the recipients' spleen cells, whereas day-6-activated T  cells increased it  (Fig. 6). 
Furthermore, upon transfer to nonirradiated 2 ° F1 mice, day-5 cells caused progressive 
thymic atrophy and  cellular  depletion,  especially of plasma  cells,  in  the  lympho- 
hemopoietic tissues (Fig. 3 A). Concomitant clinical symptoms were aplastic anemia 
and hypogammaglobulinemia (Table II). An important finding in the 2 ° F1 recipients 
of day-5 cells was  the virtually complete depletion of plasma cells and  plasma-cell 
precursors of the three major Ig classes in the lamina propria of the small intestine 
(Fig.  4A).  This,  in  combination  with  the  observed  epithelial  lesions  in  the  small 
intestine,  was  the  most  likely cause  of LGVHD and  sepsis  caused  by day-5  cells. 
Sprent and Miller (28)  observed that a substantial portion of alloactivated parental 
T  cells eventually home to the intestinal villi of 2 ° Fa recipient mice. This observation 
suggests that  the depletion of plasma  cells and  plasma-cell  precursors in  the  2 °  F1 
recipients of day-5 cells was because of a local immune response by the day-5-activated 
T  cells.  Van Bekkum et al. (29)  have demonstrated that the quality of the intestinal 
microflora can decisively influence the mortality rate of mice undergoing GVHR. It 
seems fair to conclude from the combined findings that  the primary cause of GVH 1516  ALLOSUPPRESSOR  T CELLS IN LETHAL GRAFT-VS.-HOST DISEASE 
mortality lies in the T  ceil-induced pathological damage in several tissues, including 
the gut. Thereafter, pathogenic microorganisms, invading from the damaged intestine 
and infecting an immunodeficient organism, can play an important secondary role. 
In  marked contrast with day-5 cells, transfer of day-6 cells to 2 °  F~  mice caused 
splenomegaly, lymphoid stimulation (especially of the F1 B cells), and hypergamma- 
globulinemia  (Tables II and III). An intriguing observation was that the lymphoid 
tissue of almost all the 2 ° F1 recipients of day-6 cells remained stimulated throughout 
the  3-mo  observation  period.  Thus,  the  lymphoid  stimulation  induced  by  day-6- 
activated  B10 T  cells did  not  rapidly return  to  normal  or revert to  the  lymphoid 
hypoplasia and  pancytopenia that  is characteristic of the acute GVHD induced in 
identical F1 mice by the injection of nonactivated, unselected B10 spleen cells (14). 
These results indicate that day-6-activated B10 T  cells, in contrast to unselected B 10 
spleen cells and  day-5-activated B10 T  cells, had  undergone an  almost  irreversible 
reduction  in  those  T  cells  that  induce  the  suppressive  pathological  phenomena 
characteristic of acute GVHD. These impressive functional differences between day- 
5 and day-6 cells cannot be ascribed to differences in either the number of parental 
T  cells or the Lyt phenotypes expressed by them (Table I). 
Mode of Elicitation  and Specificity of AUosuppression and Allohelp.  Apart from suppress- 
ing the IgG production of nonirradiated 2 ° F1 recipients, day-5-activated T  cells also 
suppressed the anti-levan response (Figs.  7 and 8) and erythropoiesis (Figs.  11 and 12) 
of irradiated and repopulated 2 ° Fa recipients. In addition, they suppressed the anti- 
SRBC PFC response of F1 spleen cells cultured in vitro (Fig.  10). By contrast, day-6- 
activated T  cells, in spite of an identical capacity for killing F~ target cells, failed to 
suppress  (or only weakly suppressed)  the  anti-SRBC  response of F1  spleen cells in 
vitro (Fig. 10) and the anti-levan response and erythropoiesis of irradiated 2 ° F, mice 
repopulated  with  Fa  cells  (Figs.  7  and  11). Correspondingly,  we  assume  that  the 
decrease in erythropoiesis and antibody formation caused by day-5-activated B 10 cells 
was the result of suppressive rather than cytotoxic activity. This assumption is based 
on the observation that day-5 cells were able to reduce the erythropoiesis and antibody 
formation not only of F~ cells (Figs.  7,  10 and  11)  but also, at least to some extent, 
that of syngeneic B 10 cells exposed to an F1 environment (Figs. 8 and 12). A reduction 
in the functional activities of syngeneic cells cannot be ascribed to cytotoxicity (Fig. 
5).  The extremely low number of 0.5  ×  103 day-5 cells that  effectively reduced the 
anti-SRBC  response of 3  ×  106 F1  spleen cells  (Fig.  10)  also  tends  to  support  the 
notion that this effect was because of suppression rather than cytotoxicity. 
The  elicitation  of eventually  nonspecific  suppressor  activity  depended  on  the 
aliorecognition  by  the  activated  parental  T  cells  of F1  antigens.  Whereas  day-5- 
activated B 10 cells did suppress the erythropoietic activity of B 10 cells in irradiated 
2 ° FI (Fig.  12), they completely failed to do so in the absence of F1 antigens. Further, 
day-5-activated B10 cells did not suppress the primary anti-SRBC  response of B10 
spleen cells, whereas they suppressed the response of F1 spleen ceils (Fig.  10). Once it 
was elicted, however, the suppressor activity could affect syngeneic B 10 cells as well 
(Figs.  8  and  12). Comparable  suppressor  activities,  triggered  by  specific  T  cell 
allorecognition and  nonspecifically affecting bystander cells,  have  previously been 
reported by others (6,  30, 31). The suppression exerted by day-5 cells, nevertheless, 
seemed to have a stronger effect on Fx cells than on syngeneic B 10 cells (Figs.  7 and 
11 vs. 8 and  12). One possible explanation for this phenomenon is that nonspecific as ROLINK ET AL.  1517 
well as Fa-restricted TS cells or suppressor factors operate in our model. Schwartz et 
al.  (32) described the induction of both restricted and unrestricted TS cells during a 
primary MLR, and it has been reported (33, 34) that both restricted and unrestricted 
suppressor  factors  preventing  cell  proliferation  were  produced  by  or  under  the 
influence of alloactivated T  cells. Hence, it is conceivable that more than one type of 
TS cell (or factor) was present among the day-5-activated T  cells, one type that acted 
specifically on F1 cells and another that acted nonspecifically in that it also suppressed 
B10 cells. Another explanation for the stronger suppression of F1 cells could be that 
the F1 cells, taken to repopulate the irradiated 2 ° F1 mice, provided a quantitatively 
or qualitatively better antigenic stimulus for triggering the suppression by day-5 cells. 
As far as the activity ofday-6-activated T cells in irradiated 2 ° F1 mice is concerned, 
different results were found, depending on whether the antibody-forming and eryth- 
ropoietic progenitor cells  were  of F1  or  B10  origin.  Whereas  day-6  cells  failed  to 
suppress  or  only  marginally  suppressed  the  antibody-forming  and  erythropoietic 
activity  of F~  cells  (Figs.  7  and  11),  they  did  suppress  the  antibody-forming and 
erythropoietic activity of B10 cells (Figs.  8 and  12). At least two mechanisms, which 
are mutually not exclusive, might account for this discrepancy. First, it is conceivable 
that day-6 cells produced a helper factor that was specific for F1 cells but did not act 
on B 10 cells.  Hence, the suppressive effect also exerted by day-6 cells might have been 
neutralized by an F~-specific helper factor (35) in those experiments where cells of F1 
origin were used, but not in those where B10 cells were used. An Fl-restricted helper 
effect (35, 36) might have neutralized the suppression by day-6 cells of both F~ B cells 
and  F1 erythropoietic progenitor cells because there is evidence that  activated TH 
cells release factor(s) stimulating both kinds of cells (37, 38). Second, cells from B10 
(H-2  b/b) donors are especially susceptible to F1 hybrid resistance in H-2  bm recipients 
(27,  and Table IV).  Although high numbers of B10 BMC were used to correct for 
this, the susceptibility of B 10 BMC to the combined effect of F1 hybrid resistance and 
allosuppression might have been greater than the susceptibility of small numbers of 
FI BMC to allosuppression alone. 
Possible Biological Mechanism  Underlying the Enrichment of Alloreactive TS Cells on Day 5 
and of TH Cells on Day 6.  The switch from allosuppression to allohelp from day 5 to 
day 6 was highly reproducible. Conceivably, the time dependency of this switch was 
because of time differences in the splenic sojourn and recirculation of subsets of donor 
T  cells in the  1  o F1 mice. Supposing that significant numbers of donor TS cells left 
the  spleens  of 1  °  F~  mice  between  days  5  and  6,  they might  have  left  behind  a 
population of alloreactive donor cells enriched in TH cells. Sprent and Miller (28, 39) 
previously  studied  the  functional  capacities  of parental  strain  T  cells  that  were 
activated against the H-2 alloantigens of irradiated F~ animals. The overall conclusion 
from their investigations is that donor T  cells first home to the peripheral lymphoid 
organs, including the spleen, where they proliferate and differentiate in response to 
the alloantigens of the recipients. After a  lag period of 3.5 days, the alloactivated T 
cells start re-entering the circulation. Sprent and Miller (28)  found that T  cells that 
were recovered from the circulation at  4-6  d  after the  injection into irradiated  F1 
mice had lost their specific ability to induce GVH splenomegaly when transferred to 
nonirradiated 2 °  F1 mice. They further noticed that  the same activated parental T 
cells were strongly cytotoxic for F1 target cells in vitro. This finding of but a partial 
anti-F1  reactivity of the  recirculating parental  T  cells  indicates  that,  indeed,  only 1518  ALLOSUPPRESSOR  T  CELLS IN LETHAL GRAFT-VS.-HOST DISEASE 
selected  subpopulations  of  the  alloactivated  donor  T  cells  start  to  re-enter  the 
circulation of the Fa recipient around  day 5. As far as the inability to induce GVH 
splenomegaly and the capacity for anti-F1 cytotoxicity is concerned, the recirculating 
parental  T  cells  described  by Sprent  and  Miller  (28)  resemble the  day-5-activated 
splenic T  cells described in the present paper. However, an important difference was 
the reported inability of the recirculating parental T  cells to induce LGVHD or acute 
GVHD upon transfer to 2 °  F1 mice (28).  The reason for this difference is not known 
:~t present. In the light of the T  cell circuit  (10),  it is conceivable that the induction of 
severe  allosuppression  and  eventually  LGVHD  requires  at  least  two  subsets  of 
alloactivated parental T cells: (a) an effector cell population mediating allosuppression 
that  might have been present  among both day-5 cells and the recirculating T  cells, 
and  (b) an additional  helper cell population that keeps inducing  (10)  the suppressor 
effector cells. Possibly, this second subset of parental T  cells does not recirculate and 
thus was present only among the day-5 cells obtained from the spleens of the  1  o FI 
recipients,  In any event,  the early observation  (28)  that  anti-Fx  cytotoxicity of the 
activated parental T  cells is not sufficient for induction of acute GVHD and LGVHD 
has  long  been  overlooked  by  investigators  in  the  field  (16-19).  This  important 
observation  has been confirmed and  extended  by the data  of the present  study,  as 
discussed below. 
Lack of a Distinct Role of TK Cells in the Pathogenesis of LGVHD.  Interestingly, day-5- 
activated T  cells and day-6-activated T  cells had equal capacity to lyse F1 target cells 
in vitro (Fig. 5). The good anti-F1 cytotoxicity of day-6 cells, which were incapable of 
inducing  LGVHD,  indicated  that  donor TK cells are  insufficient  for induction  of 
LGVHD. Our concept that LGVHD is caused not by TK but by alloreactive TS cells 
is further supported by theoretical considerations. In view of the tremendous regener- 
ative capacity of the  iympho-hemopoietic tissue,  it  has been argued  that  a  general 
suppression  of cell  proliferation  by  TS  cells  would  be  much  more  efficient  than 
cytotoxicity to cause cellular depletion  in that  tissue  (13).  A  general  suppression  of 
cell proliferation should cause a  depletion  of most of the lympho-hemopoietic bone 
marrow  cells  because  they  are  short-lived,  but  not  of  the  neighboring  reticular 
fibroblasts that  are long-lived  (40).  This is precisely what  we observed in  the  2 °  F1 
recipients of day-5 cells (Fig.  3 A). Although  fibroblasts can be killed by alloreactive 
TK cells in vitro (41), they were not visibly damaged or reduced  in numbers by the 
cytotoxic T  cells present among day-5 and day-6 cells. In conclusion, both experimen- 
tal evidence and theoretical reasoning indicate that donor TK cells alone are incapable 
of inducing LGVHD. On the other hand, no donor-cell population that is devoid of 
cytotoxic anti-F1 activity while maintaining the capacity for induction of LGVHD is 
now available. Hence, on the basis of the available data, we cannot exclude a limited 
participation of donor TK cells in the pathogenesis of LGVHD. A  possible place of 
TK cell activity was the small intestine, where lymphocytes invading the epithelium 
were noticed. This, however, was found in the 2 ° F1 recipients of both day-5 and day- 
6 cells.  Hence, lymphocytic invasion of the intestinal  epithelium  cannot account, or 
cannot account alone, for the sepsis and LGVHD exclusively induced by day-5 cells. 
Possibly, in the GVHR, alloreactive TK cells of the donor are readily blocked by 
the large excess of alloantigen-bearing cells of the recipient. Whatever the explanation, 
we were impressed by the fact that  in  two other models of T  cell reactivity in  vivo, ROLINK ET AL.  1519 
too, no functional role of TK cells could be detected, although such cells were readily 
demonstrable in vitro  (42,  43).  It appears that  cytotoxicity is an  exceptional T  cell 
function because it is performed by T  cells  themselves. Instead, the main function of 
T  lymphocytes as a  class appears to be an indirect one in that T  cell subsets act by 
regulating, mainly through the release of factors, the function of other cells,  such as 
lymphocytes,  macrophages,  and  the  progenitors  of erythrocytes,  monocytes,  and 
myeloid ceils  (10, 37, 38). The results of the present investigation fit into this general 
concept. Conceivably, a better understanding of stimulatory GVH mechanisms that 
cause the  hypergammaglobulinemia and  lymphadenopathy, on  the one hand,  and 
the suppressive mechanisms that cause the hypogammaglobulinemia, aplastic anemia, 
and  pancytopenia  of LGVHD,  on  the  other  hand,  will  eventually  improve  our 
understanding of the same pathological conditions that develop after viral infections 
or exposure to sensitizing drugs. There is reason to assume that GVH-like reactions to 
"altered-self" structures on lympho-hemopoietic cells can underly all these conditions 
(9). 
Summary 
Splenic T  cells  from B10 donors were injected  into irradiated  (B10 ×  DBA/2)F1 
mice. Either 5 or 6 d later, activated donor T  cells were recovered from the spleens of 
these  primary  FI  (1 °  Fa)  recipients  and  transferred  to  groups  of  nonirradiated 
syngeneic F1 (2 ° F:) recipients. Whereas day-5-activated parental T  cells induced the 
characteristic symptoms of acute graft-vs.-host disease (GVHD) and eventually lethal 
GVHD,  day-6-activated  B10  T  cells  failed  to  induce  acute  GVHD  but  induced 
symptoms of chronic GVHD. Interestingly, the inability of day-6-activated T  cells  to 
induce lethal GVHD could not be ascribed to a lack in anti-F1 T  killer cells. 
The combined results of functional studies indicated that day-6 cells were enriched 
for  alloreactive  helper  T  cells,  whereas  day-5  cells  were  enriched  for  alloreactive 
suppressor cells.  Hence, our findings indicate that  acute GVHD and lethal GVHD 
are caused by alloreactive donor T suppressor but not T killer cells, and that symptoms 
of chronic GVHD are caused by alloreactive donor T  helper cells. 
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